Tom Reilly is a seasoned financial leader with extensive expertise in financial planning, analysis, accounting, and controlling. Currently serving as the Chief Financial Officer at Opthea Limited since 2024, Tom previously held the CFO position at Amarin Corporation from 2022 to 2024 and Cara Therapeutics from 2020 to 2022. With a robust background in various financial roles at Novartis, including Director of Financial Planning/Analysis and Accounting, Tom has successfully managed large teams and driven significant financial results throughout their career. Tom holds an MBA in Accounting from Seton Hall University and a Bachelor's degree in Finance from Manhattan College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices